Tavexia Lifecare Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 3,73,368 shares,. Its Average Traded Price (ATP) is ₹1.17, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 10000 @ ₹1.18.
Tavexia Lifecare has an upper circuit limit of ₹1.23 and a lower circuit limit of ₹1.13. The total value traded stands at ₹4.37 L, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1. Tavexia Lifecare also offers a dividend yield of 0%.
Tavexia Lifecare Share Price Chart
Tavexia Lifecare Share Key Metrics
Volume
3.73 L
Market Cap
45.26 CR
LTQ@LTP
10000@1.18
ATP
1.17
Var Margin
100 %
Circuit Range
1.13-1.23
Delivery %
100 %
Value
4.37 L
ASM/GSM
No
Market Lot
1
Tavexia Lifecare Resistance and Support
Pivot 1.17
Resistance
First Resistance
1.2
Second Resistance
1.22
Third Resistance
1.25
Support
First Support
1.15
Second Support
1.12
Third Support
1.1
Tavexia Lifecare Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Tavexia Lifecare Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-07 | Others |
| 2026-09-04 | A.G.M. |
| 2026-08-04 | Quarterly Results |
| 2026-06-30 | Others |
| 2026-06-04 | Audited Results |
| 2026-05-30 | Audited Results |
| 2026-02-19 | Quarterly Results |
| 2026-02-16 | Quarterly Results |
| 2026-02-14 | Quarterly Results |
| 2025-11-25 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-09-03 | Others |
| 2025-08-12 | Quarterly Results |
| 2025-06-21 | Others |
| 2025-05-05 | Audited Results & Rights issue |
| 2025-04-30 | Audited Results & Rights issue |
| 2025-04-23 | Others |
| 2025-02-11 | Quarterly Results |
| 2025-01-25 | Others |
| 2025-01-18 | Allotment of Bonus shares |
| 2024-12-02 | Bonus issue |
| 2024-11-12 | Quarterly Results |
| 2024-08-30 | Stock Split & A.G.M. |
| 2024-08-16 | Rights issue |
| 2024-08-05 | Quarterly Results |
| 2023-10-11 | Others |
| Bonus Date | Record Date | |
|---|---|---|
| 2024-12-02 | 2025-01-17 | View More |
| Rights Date | Ratio | |
|---|---|---|
| 2025-05-09 | 5:2 | View More |
| Split Ratio | Split Date | |
|---|---|---|
| 5:1 | 2024-10-25 | View More |
Tavexia Lifecare News
Tavexia Lifecare Ltd - 539519 - Announcement Under Regulation 30
Sattva Sukun Lifecare (Tavexia Lifecare) is acquiring a 60% controlling stake in Meyonex Pharmaceuticals for Rs.67.19 crores. The acquisition will be executed through a cash subscription of 2.09 crore fresh equity shares at Rs.32 per share, expanding the company's presence into API and CDMO segments.
Oct 12 2026 18:44:39
Tavexia Lifecare Ltd - 539519 - Announcement Under Regulation 30
Sattva Sukun Lifecare (Tavexia Lifecare) announced a business expansion into APIs and CDMO segments by altering its Main Object Clause. The board approved acquiring a 60% controlling stake in Meyonex Pharmaceuticals for Rs.67.19 crore to establish an operational foothold. The company also plans to initiate fund-raising to finance this acquisition.
Oct 12 2026 15:16:31
Tavexia Lifecare Ltd - 539519 - Disclosure Under Regulation 30
Sattva Sukun Lifecare board has approved the acquisition of a 60% stake in Meyonex Pharmaceuticals via a fresh share subscription worth Rs.67.19 crore. The board also granted in-principle approval for a related fundraise to finance the transaction.
Oct 07 2026 22:46:23
Tavexia Lifecare Ltd - 539519 - Board Meeting Outcome for Outcome Of Board Meeting
Sattva Sukun Lifecare board has approved the acquisition of a 60% stake in Meyonex Pharmaceuticals for a cash consideration of ₹67.19 crores at ₹32 per share. Additionally, the board granted in-principle approval to raise funds via a preferential or rights issue to finance the deal.
Oct 07 2026 22:43:00
Tavexia Lifecare Ltd - 539519 - Board Meeting Intimation for Intimation Of Board Meeting
Sattva Sukun Lifecare's board of directors is scheduled to meet on October 7, 2026. The meeting will focus on the proposed acquisition of up to 60% equity in Meyonex Pharmaceuticals and review the progress of ongoing due diligence and negotiations.
Sep 29 2026 20:29:04
Tavexia Lifecare Ltd - 539519 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Sattva Sukun Lifecare's promoters, Roshan Dealmark Private Limited and Puja Agarwal, disposed of 7 lakh equity shares through an on-market transaction on September 25, 2026. This sale reduced their collective shareholding in the company by 0.182%.
Sep 26 2026 11:03:09
Tavexia Lifecare Ltd - 539519 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Sattva Sukun Lifecare's promoter group, Roshan Dealmark Private Limited, disposed of 400,000 equity shares through an on-market trade on September 23, 2026. This transaction reduced the promoter group's overall shareholding by 0.104% to 3.947%.
Sep 24 2026 09:34:58
Tavexia Lifecare Ltd - 539519 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Sattva Sukun Lifecare promoters Roshan Dealmark Private Limited and Puja Agarwal disposed of 9.07 lakh shares (0.237% stake) through an on-market transaction on September 21, 2026. This reduces their total holding to 4.051%.
Sep 22 2026 11:56:26
Tavexia Lifecare Management
| Name | Position |
|---|---|
| Poonam Rani | Company Secretary & Compliance Officer |
| Mit Tarunkumar Brahmbhatt | Managing Director |
Tavexia Lifecare FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in TAVEXIA
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC